We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBUX icon
276
Starbucks
SBUX
$119B
$276K 0.01%
2,583
-50
-2% -$4.77K
SRRK icon
277
Scholar Rock
SRRK
$6.32B
$275K 0.01%
+5,670
New +$206K
AMN icon
278
AMN Healthcare
AMN
$1.42B
$273K 0.01%
3,998
– –
EFOR
279
Everforth Inc
EFOR
$1.33B
$252K 0.01%
+3,013
New +$232K
BKU icon
280
Bankunited
BKU
$3.3B
$242K 0.01%
+6,946
New +$198K
BMY icon
281
Bristol-Myers Squibb
BMY
$132B
$240K 0.01%
3,870
– –
TCBI icon
282
Texas Capital Bancshares
TCBI
$4.32B
$235K 0.01%
+3,952
New +$195K
MLKN icon
283
MillerKnoll
MLKN
$1.64B
$233K 0.01%
6,896
– –
CMD
284
DELISTED
Cantel Medical Corporation
CMD
$223K 0.01%
+2,826
New +$166K
HELE icon
285
Helen of Troy
HELE
$680M
$220K 0.01%
+990
New +$204K
EVR icon
286
Evercore
EVR
$11.5B
$218K 0.01%
+1,989
New +$177K
OHI icon
287
Omega Healthcare
OHI
$14.4B
$217K 0.01%
+5,985
New +$203K
IDA icon
288
Idacorp
IDA
$8.08B
$214K 0.01%
+2,231
New +$203K
CACI icon
289
CACI
CACI
$14.3B
$207K 0.01%
+832
New +$192K
FNB icon
290
FNB Corp
FNB
$6.75B
$206K 0.01%
21,714
– –
THO icon
291
Thor Industries
THO
$4.14B
$206K 0.01%
2,211
– –
WKC icon
292
World Kinect Corp
WKC
$1.89B
$204K 0.01%
+6,534
New +$174K
KSU
293
DELISTED
Kansas City Southern
KSU
$204K 0.01%
+1,000
New +$188K
JLL icon
294
Jones Lang LaSalle
JLL
$16.4B
$203K 0.01%
+1,366
New +$175K
HOPE icon
295
Hope Bancorp
HOPE
$1.79B
$186K 0.01%
17,075
– –
LXP icon
296
LXP Industrial Trust
LXP
$3.58B
$181K 0.01%
3,411
– –
PDM
297
Piedmont Realty Trust
PDM
$1.16B
$170K 0.01%
10,487
– –
BRKL
298
DELISTED
Brookline Bancorp
BRKL
$155K 0.01%
12,879
– –
FHN icon
299
First Horizon
FHN
$12B
$131K ﹤0.01%
10,302
– –
NMRK icon
300
Newmark Group
NMRK
$2.52B
$116K ﹤0.01%
15,971
– –
9 10 11
12
13

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.